Preliminary experiments show conolidine may possibly inhibit precise ion channels, decreasing neuronal excitability and limiting pain indicators. This mechanism is particularly relevant in neuropathic pain, where abnormal signaling results in persistent pain. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to agony perception. https://katej402zxu1.homewikia.com/user